Jesse Solomon

Davis Polk advised Coloplast on its acquisition of Nine Continents Medical, an early stage company pioneering an implantable tibial nerve stimulation treatment for over-active bladder. The…

Davis Polk is advising Bristol Myers Squibb on its acquisition of Forbius. The transaction includes an upfront payment and future success-based milestone payments. The transaction is…

Davis Polk is advising Clarivate Plc on its approximately $6.8 billion combination with CPA Global. In the all-stock transaction, CPA Global shareholders will receive approximately 218…

Davis Polk advised Outotec Oyj as to U.S. law in connection with the demerger by Metso Corporation’s minerals business by way of transfer (without liquidation of Metso) to Outotec and…

Davis Polk is advising Novo Nordisk A/S on its acquisition of Corvidia Therapeutics Inc. for an upfront payment of $725 million in cash. Total payments to Corvidia Therapeutics shareholders…

Davis Polk is advising PepsiCo on the U.S. antitrust and tax aspects of its acquisition of Rockstar Energy Beverages for $3.85 billion and future payments in respect of tax benefits…

Davis Polk is advising Clarivate Analytics plc in connection with its $950 million acquisition of Decision Resources Group from Piramal Enterprises Limited. The $950 million purchase price…

Davis Polk advised Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc., including coordinating all international regulatory filings.  The acquisition was…

Davis Polk is advising Attunity Ltd. on its approximately $560 million acquisition by Qlik Technologies Inc. The transaction, which is expected to close in the second quarter of 2019, is…

Davis Polk is advising Millicom International Cellular S.A. on its $1.65 billion acquisition of the entire share capital of Telefónica Móviles Panamá, S.A., Telefónica de Costa Rica TC, S.A…